Blast Overpressure Longitudinal Study
BLES
2 other identifiers
observational
250
1 country
3
Brief Summary
The goal of this observational study is to learn about the impact of low-level blast exposure in U.S. Special Operations Forces personnel. The main questions it aims to answer are: What advanced brain imaging changes are related to clinical presentation after low-level blast exposure? What are the relationships between low-level blast exposure and common groups of symptoms after concussion? Participants will:
- Undergo advanced brain imaging
- Answer questionnaires
- Complete clinical tests
- Provide blood, urine, and saliva samples
- Wear blast sensors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2026
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2030
May 26, 2026
March 1, 2026
4.3 years
March 24, 2026
May 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effective axonal radii mapping
The primary outcome measure in this study will be effective axonal radii (r\_eff) mapping derived from ultra-high performance diffusion magnetic resonance imaging using the MAGNUS system and its correlations to low-level blast exposure.
At baseline and annually through study completion, an average of 5 years
Secondary Outcomes (32)
Ohio State University TBI Identification Method
At baseline and annually through study completion, an average of 5 years
Concussion Clinical Profiles Screening
At baseline and annually through study completion, an average of 5 years
Neurobehavioral Symptom Inventory
At baseline and weekly through study completion, an average of 5 years
Headache Impact Test
At baseline and weekly through study completion, an average of 5 years
modified Military Concussion Readiness Inventory for Dizziness and Balance
At baseline and quarterly through study completion, an average of 5 years
- +27 more secondary outcomes
Other Outcomes (3)
quantitative EEG via the NeuroCatch®
At baseline and quarterly through study completion, an average of 5 years
Blast sensor-measurement of blast exposure(s)
Daily through study completion, an average of 5 years
Self-report of blast exposure(s)
Daily through study completion, an average of 5 years
Study Arms (2)
High exposure (experimental)
Special Operations Forces personnel with higher occupational blast overpressure exposure as measured by blast sensor(s)
Low/No exposure (control)
Special Operations Forces personnel with lower occupational blast overpressure exposure as measured by blast sensor(s)
Eligibility Criteria
The target population is 250 SOF personnel, particularly those who are regularly exposed to occupational low-level blast exposure. Approximately 10% of the sample will be recruited as a control group of low/no exposure personnel.
You may qualify if:
- Active duty
- U.S. SOF personnel
- years old
You may not qualify if:
- Subjects will be excluded only if their participation will significantly interfere with validity of data collection or safety during the study (e.g., they have conditions that might result in harm or injury during research procedures).
- Example: pregnancy (balance considerations)
- Example: being unable to undergo MRI testing (i.e., they have non-MRI compatible devices, imbedded metal fragments such as shrapnel, and/or severe claustrophobia; these MRI contraindications will be screened using an MRI Safety Questionnaire)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uniformed Services University of the Health Scienceslead
- The Geneva Foundationcollaborator
- MIT Lincoln Laboratorycollaborator
Study Sites (3)
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
Fort Bragg
Fort Bragg, North Carolina, 28310, United States
Wilford Hall Ambulatory Surgical Center
San Antonio, Texas, 78236, United States
Biospecimen
blood; saliva; urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vincent B Ho, MD
Uniformed Services University of the Health Sciences
- PRINCIPAL INVESTIGATOR
Tony T Yuan, PhD
Uniformed Services University of the Health Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2026
First Posted
May 26, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 1, 2030
Study Completion (Estimated)
August 1, 2030
Last Updated
May 26, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Research data may be shared, when permitted by USSOCOM, upon reasonable request to the Principal Investigator.